Orally administered, nonabsorbable antibiotics were effective in eradicating carbapenem-resistant Enterobacteriaceae (CRE) colonization, according to a new study published in the December issue of the American Journal of Infection Control, a publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Researchers at Rambam Health Care Campus, a 1,000-bed, tertiary care center in Haifa, Israel, examined isolates from 152 patients who were identified as CRE carriers (colonized with the organism, but not yet showing disease) over a 24-month period. There were 50 patients in the treatment group, who received one of three drug regimens based on antibiotic sensitivities of their isolates: nonabsorbable gentamicin (26), colistin (16), or a combination of the two (8). Patients received treatment until cultures were negative for CRE, or for a maximum of 60 days.
Patients not sensitive to either antibiotic, or those who did not give consent (102), comprised the control group and were also followed (median=140 days) in order to determine the spontaneous eradication rate.
CRE was eradicated in 42 percent of patients taking gentamicin (11/26), 50 percent taking colistin (8/16), and 37.5 percent taking a combined treatment (3/8), for an overall eradication rate for patients on all treatment regimens of 44 percent (22/50). This compares to a 7 percent (7/102) eradication rate in the control group.
In patients where colonization was stamped out, regardless of whether they received treatment, there were fewer deaths than in those where colonization persisted (17 percent vs. 49 percent, respectively).
"Treatment with oral nonabsorbable antibiotics, to which CRE is susceptible, appears to be safe and effective for eradication of the CRE carrier state," say the researchers in the study. "Reducing the reservoir of CRE carriers in healthcare facilities may thereby reduce patient-to-patient transmission and the incidence of clinical infection with this difficult-to-treat organism. When mortality rate in patients who had successful eradication of the carrier state (either spontaneous or on treatment) was compared with that of patients failing eradication, significantly lower mortality was found in the former group. This could point toward a real reduction of mortality attributed to the eradication of CRE carrier state."
According to the U.S. Centers for Disease Control and Prevention (CDC), untreatable and hard-to-treat infections from CRE are on the rise among patients in medical facilities. These bacteria have become resistant to nearly all the antibiotics currently available and can transfer their resistance to other organisms. According to the CDC, almost half of patients who get bloodstream infections from CRE germs die from the infections.
Explore further: Admission screenings find superbug infections in Virginia
More information: www.ajicjournal.org/article/S0196-6553%2813%2900889-4/fulltext
Journal reference: American Journal of Infection Control
Provided by Association for Professionals in Infection Control
Medical Xpress on facebook
Related Stories
Admission screenings find superbug infections in Virginia
Jul 09, 2013
Antibiotic-resistant superbugs like carbapenem-resistant Enterobacteriaceae (CRE) present a challenge to healthcare professionals as patients move from different care settings and facilities, unknowingly spreading healthcare-associated ...
Superbug CRE may endure in patients one year after initial infection
Feb 27, 2013
Patients who tested positive for carbapenem-resistant Enterobacteriaceae (CRE) took an average of 387 days following hospital discharge to be clear of the organism, according to a new study published in the March issue of ...
US warns over deadly, hard-to-treat bacteria (Update)
Mar 05, 2013
A deadly strain of hard-to-treat bacteria is spreading in US health facilities, posing a particular risk to the nation's most vulnerable patients, authorities said in a report on Tuesday.
CDC sounds alarm on antibiotic-resistant bacteria
Sep 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday ...
Promiscuity of resistance plasmid unprecedented
Jan 04, 2012
Genetic analysis of an outbreak of drug-resistant infections in one institution shows an unprecedented level of transference of resistance among strains and even species of bacteria. Researchers from the University of Virginia ...
Recommended for you
Got the sniffles? Migraines spike with allergies and hay fever
3 hours ago
People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according ...
Saudi announces 55th MERS death
Nov 24, 2013
The Saudi health ministry on Sunday announced a new MERS death, raising to 55 the number of people killed by the coronavirus in the country with the most fatalities.
Stuck on flu: How a sugar-rich mucus barrier traps the virus—and it gets free to infect
Nov 23, 2013
Researchers at the University of California, San Diego School of Medicine have shown for the first time how influenza A viruses snip through a protective mucus net to both infect respiratory cells and later ...
Using data to fight malaria
Nov 22, 2013
The University of California, Riverside announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Yanping Chen will pursue an innovative ...
Qatar announces fourth MERS death
Nov 22, 2013
An expatriate living in Qatar has died of MERS, bringing to four the number of deaths in the Gulf state from the coronavirus, health authorities said on Friday.
What not to do for migraines
Nov 21, 2013
(HealthDay)—Prescription pain medications should not be the first treatment for migraines. And doctors shouldn't routinely order brain scans for patients with these debilitating headaches, according to ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Orally administered, nonabsorbable antibiotics were effective in eradicating carbapenem-resistant Enterobacteriaceae (CRE) colonization, according to a new study published in the December issue of the American Journal of Infection Control, a publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Researchers at Rambam Health Care Campus, a 1,000-bed, tertiary care center in Haifa, Israel, examined isolates from 152 patients who were identified as CRE carriers (colonized with the organism, but not yet showing disease) over a 24-month period. There were 50 patients in the treatment group, who received one of three drug regimens based on antibiotic sensitivities of their isolates: nonabsorbable gentamicin (26), colistin (16), or a combination of the two (8). Patients received treatment until cultures were negative for CRE, or for a maximum of 60 days.
Patients not sensitive to either antibiotic, or those who did not give consent (102), comprised the control group and were also followed (median=140 days) in order to determine the spontaneous eradication rate.
CRE was eradicated in 42 percent of patients taking gentamicin (11/26), 50 percent taking colistin (8/16), and 37.5 percent taking a combined treatment (3/8), for an overall eradication rate for patients on all treatment regimens of 44 percent (22/50). This compares to a 7 percent (7/102) eradication rate in the control group.
In patients where colonization was stamped out, regardless of whether they received treatment, there were fewer deaths than in those where colonization persisted (17 percent vs. 49 percent, respectively).
"Treatment with oral nonabsorbable antibiotics, to which CRE is susceptible, appears to be safe and effective for eradication of the CRE carrier state," say the researchers in the study. "Reducing the reservoir of CRE carriers in healthcare facilities may thereby reduce patient-to-patient transmission and the incidence of clinical infection with this difficult-to-treat organism. When mortality rate in patients who had successful eradication of the carrier state (either spontaneous or on treatment) was compared with that of patients failing eradication, significantly lower mortality was found in the former group. This could point toward a real reduction of mortality attributed to the eradication of CRE carrier state."
According to the U.S. Centers for Disease Control and Prevention (CDC), untreatable and hard-to-treat infections from CRE are on the rise among patients in medical facilities. These bacteria have become resistant to nearly all the antibiotics currently available and can transfer their resistance to other organisms. According to the CDC, almost half of patients who get bloodstream infections from CRE germs die from the infections.
Explore further: Admission screenings find superbug infections in Virginia
More information: www.ajicjournal.org/article/S0196-6553%2813%2900889-4/fulltext
Journal reference: American Journal of Infection Control
Provided by Association for Professionals in Infection Control
Medical Xpress on facebook
Related Stories
Admission screenings find superbug infections in Virginia
Jul 09, 2013
Antibiotic-resistant superbugs like carbapenem-resistant Enterobacteriaceae (CRE) present a challenge to healthcare professionals as patients move from different care settings and facilities, unknowingly spreading healthcare-associated ...
Superbug CRE may endure in patients one year after initial infection
Feb 27, 2013
Patients who tested positive for carbapenem-resistant Enterobacteriaceae (CRE) took an average of 387 days following hospital discharge to be clear of the organism, according to a new study published in the March issue of ...
US warns over deadly, hard-to-treat bacteria (Update)
Mar 05, 2013
A deadly strain of hard-to-treat bacteria is spreading in US health facilities, posing a particular risk to the nation's most vulnerable patients, authorities said in a report on Tuesday.
CDC sounds alarm on antibiotic-resistant bacteria
Sep 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday ...
Promiscuity of resistance plasmid unprecedented
Jan 04, 2012
Genetic analysis of an outbreak of drug-resistant infections in one institution shows an unprecedented level of transference of resistance among strains and even species of bacteria. Researchers from the University of Virginia ...
Recommended for you
Got the sniffles? Migraines spike with allergies and hay fever
3 hours ago
People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according ...
Saudi announces 55th MERS death
Nov 24, 2013
The Saudi health ministry on Sunday announced a new MERS death, raising to 55 the number of people killed by the coronavirus in the country with the most fatalities.
Stuck on flu: How a sugar-rich mucus barrier traps the virus—and it gets free to infect
Nov 23, 2013
Researchers at the University of California, San Diego School of Medicine have shown for the first time how influenza A viruses snip through a protective mucus net to both infect respiratory cells and later ...
Using data to fight malaria
Nov 22, 2013
The University of California, Riverside announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Yanping Chen will pursue an innovative ...
Qatar announces fourth MERS death
Nov 22, 2013
An expatriate living in Qatar has died of MERS, bringing to four the number of deaths in the Gulf state from the coronavirus, health authorities said on Friday.
What not to do for migraines
Nov 21, 2013
(HealthDay)—Prescription pain medications should not be the first treatment for migraines. And doctors shouldn't routinely order brain scans for patients with these debilitating headaches, according to ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment